📍 Whitefield, Bangalore
HOD & Senior Consultant · Surgical Oncology
Consultation by Appointment

Patient Resources / HIPEC vs PIPAC

HIPEC vs PIPAC: What's the Difference?

Two specialist treatments for cancer that has spread to the lining of the abdomen (peritoneal cancer). This guide explains how they differ, who may be considered for each, and what to discuss with your treating team.

Short answer: HIPEC is heated chemotherapy given during major open cytoreductive surgery, usually as a single session, for disease that can be completely removed. PIPAC is chemotherapy given as a pressurised aerosol at normal body temperature through keyhole (laparoscopic) surgery. It can be repeated, often every 4 to 6 weeks, and is considered for more extensive disease or for patients not suited to major surgery. The two generally serve different patients.
HIPEC infographic: heated chemotherapy delivered into the abdomen during cytoreductive surgery
Figure 1. HIPEC: heated chemotherapy given during cytoreductive surgery, usually as a single session.
PIPAC infographic: pressurised aerosol chemotherapy delivered through keyhole surgery
Figure 2. PIPAC: pressurised aerosol chemotherapy given laparoscopically, which can be repeated.

Comparison at a glance

FeatureHIPECPIPAC
Full nameHyperthermic Intraperitoneal ChemotherapyPressurised Intraperitoneal Aerosol Chemotherapy
How the drug is givenHeated chemotherapy, about 41 to 43 °C (106 to 109 °F), delivered into the abdomenChemotherapy as a pressurised aerosol at normal body temperature
SurgeryMajor open cytoreductive surgeryKeyhole (laparoscopic) surgery
Number of sessionsUsually a single sessionRepeatable, often every 4 to 6 weeks
Typical useLimited disease that can be completely removedExtensive disease, or patients not suited to major surgery
Typical hospital stayAbout 10 to 21 daysAbout 1 to 3 days

Who may be considered

  • HIPEC: selected patients with peritoneal spread from ovarian, colorectal, appendiceal or gastric cancer, whose disease is confined enough for complete removal to be realistic. HIPEC is also used for peritoneal mesothelioma.
  • PIPAC: selected patients with peritoneal spread from ovarian, gastric, colorectal or appendiceal cancer, for whom it may help control symptoms or disease when CRS-HIPEC is not suitable.

Candidacy is always individual. Imaging and, where needed, diagnostic laparoscopy show how far the disease has spread.

How the decision is made

  1. Evaluation: imaging and, where needed, diagnostic laparoscopy to assess the extent of peritoneal disease.
  2. Multidisciplinary review: a tumour board discussion confirms candidacy for CRS-HIPEC or PIPAC.
  3. Treatment: for CRS-HIPEC, cytoreductive surgery removes visible disease, followed by heated intraperitoneal chemotherapy where indicated.
  4. Recovery and follow-up: a structured recovery plan with monitoring for recurrence.

Benefits and limitations

CRS-HIPEC is a major undertaking, suited to carefully selected patients. PIPAC is a less invasive, repeatable option for a different group of patients. PIPAC is a newer treatment, much of its evidence comes from small studies, and many of its uses are still being studied. Results and practice can vary between hospitals, so ask your team about their experience.

Frequently asked questions

Is PIPAC an alternative to HIPEC?

Not in a simple sense. The two generally serve different patients. HIPEC is for limited disease that can be completely removed by surgery, and PIPAC is for more extensive disease or for patients not suited to major surgery. Which one applies, if either, is decided after evaluation.

Which procedure is more invasive?

HIPEC involves major open surgery. PIPAC is performed laparoscopically (keyhole) and is described as minimally invasive.

How many treatments are needed?

HIPEC is usually a single session. PIPAC is repeatable, often every 4 to 6 weeks.

Which cancers are treated?

Both are used for peritoneal spread from ovarian, colorectal, appendiceal and gastric cancers. HIPEC is also used for peritoneal mesothelioma.

Who makes the decision?

A multidisciplinary tumour board reviews each patient before a decision is made.

Next steps

If you are deciding between these options, you can request an expert opinion before any treatment decision. The information on this page is general and does not replace an evaluation by your treating team.

Dr Ashwin K.R., Senior Consultant, Aster Whitefield, Bangalore.

Related guides

Medically reviewed by Dr Ashwin K.R. on 10 October 2026.